Moderna expects to launch up to 15 new products over the next five years 'addressing high unmet needs.'
Moderna stock was rising Wednesday after the vaccine maker released positive results from a Phase 3 trial of its mRNA flu vaccine and provided insight on its plans for other vaccines targeting cancer and other diseases.
“With today’s positive Phase 3 flu results, along with previous results in Covid and RSV, we are now three for three on advancing respiratory disease programs to positive Phase 3 data,” Chief Executive Stéphane Bancel said in the news release. The concern that a lack of Covid-19 demand will impact the company’s balance sheet has continued to hit shares, with the stock tumbling 41% this year while the S&P 500 has climbed 16%.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
AUD/USD rises sharply on positive China’s news, risk-on sentimentThe Australian Dollar (AUD) climbs sharply against the US Dollar (USD) during the North American session on positive news from China ahead of Aussie’s
Baca lebih lajut »
Moderna aims to prove it’s ‘more than a COVID company’As COVID vaccine sales fall, Moderna releases positive results from mRNA flu vaccine, adds new development programs
Baca lebih lajut »
S&P 500 rises as tesla, big tech rack up gains By Investing.comS&P 500 rises as tesla, big tech rack up gains
Baca lebih lajut »
Immatics shares rise on Moderna cancer collaborationImmatics NV shares gained more than 6% premarket on Monday after the company announced a collaboration with Moderna Inc. to research and develop new cancer...
Baca lebih lajut »
Moderna ties up with Immatics to boost cancer vaccine developmentModerna said on Monday it has struck a deal with German drug developer Immatics for developing cancer vaccines and therapies, and would pay $120 million in cash and additional milestone payments.
Baca lebih lajut »
Stocks making the biggest moves midday: Tesla, Qualcomm, Meta, Moderna and moreThese are the stocks posting the largest moves in midday trading.
Baca lebih lajut »